Use of invisible near infrared light fluorescence with indocyanine green and methylene blue in urology. Part 2

被引:19
作者
Polom, Wojciech [1 ]
Markuszewski, Marcin [1 ]
Rho, Young Soo [2 ]
Matuszewski, Marcin [1 ]
机构
[1] Med Univ Gdansk, Dept Urol, 1 Smoluchowskiego St, PL-80402 Gdansk, Poland
[2] Univ Med Sci, Poznan, Poland
关键词
near infrered light; fluorescence; indocyanine green;
D O I
10.5173/ceju.2014.03.art19
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction In the second part of this paper, concerning the use of invisible near infrared light (NIR) fluorescence with indocyanine green (ICG) and methylene blue (MB) in urology, other possible uses of this new technique will be presented. In kidney transplantation, this concerns allograft perfusion and real time NIR-guided angiography; moreover, perfusion angiography of tissue flaps, NIRF visualization of ureters, NIR-guided visualization of urinary calcifications, NIRF in male infertility and semen quality assessment. In this part, we have also analysed cancer targeting and imaging fluorophores as well as cost benefits associated with the use of these new techniques. Material and methods PubMed and Medline databases were searched for ICG and MB use in urological settings, along with data published in abstracts of urological conferences. Results Although NIR-guided ICG and MB are still in their initial phases, there have been significant developments in a few more major domains of urology, including 1) kidney transplantation: kidney allograft perfusion and vessel reconstruction; 2) angiography perfusion of tissue flaps; 3) visualization of ureters; 4) visualization of urinary calcifications; and 5) NIRF in male infertility and semen quality assessment. Conclusions Near infrared technology in urology is at its early stages. More studies are needed to assess the true potential and limitations of the technology. Initial studies show that this pioneering tool may influence various aspects of urology.
引用
收藏
页码:310 / 313
页数:4
相关论文
共 25 条
  • [1] CHANGING INCIDENCE AND ETIOLOGY OF IATROGENIC URETERAL INJURIES
    ASSIMOS, DG
    PATTERSON, LC
    TAYLOR, CL
    [J]. JOURNAL OF UROLOGY, 1994, 152 (06) : 2240 - 2246
  • [2] Chahin Fadi, 2002, JSLS, V6, P49
  • [3] A low molecular weight PSMA-based fluorescent imaging agent for cancer
    Chen, Ying
    Dhara, Surajit
    Banerjee, Sangeeta Ray
    Byun, Youngjoo
    Pullambhatla, Mrudula
    Mease, Ronnie C.
    Pomper, Martin G.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 390 (03) : 624 - 629
  • [4] Effectiveness and cost analysis of different methods of anti-refluxive operations in VUR grade 3 in a single institution
    Comploj, Evi
    Mian, Michael
    Koen, Mark
    Becker, Tanja
    Berger, Christoph
    Riccabona, Marcus
    [J]. CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2010, 63 (03) : 129 - 131
  • [5] Cortes-Gutierrez EI, 2014, ANDROLOGIA
  • [6] PHARMACOKINETICS OF HIGHLY IONIZED DRUGS .2. METHYLENE-BLUE - ABSORPTION, METABOLISM, AND EXCRETION IN MAN AND DOG AFTER ORAL ADMINISTRATION
    DISANTO, AR
    WAGNER, JG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (07) : 1086 - &
  • [7] PHARMACOKINETICS OF HIGHLY IONIZED DRUGS .1. METHYLENE-BLUE - WHOLE-BLOOD, URINE, AND TISSUE ASSAYS
    DISANTO, AR
    WAGNER, JG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (04) : 598 - &
  • [8] Ureteral injuries: External and iatrogenic
    Elliott, SP
    McAninch, JW
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2006, 33 (01) : 55 - +
  • [9] A novel method of imaging calcium urolithiasis using fluorescence
    Figueiredo, Jose Luiz
    Passerotti, Carlo C.
    Sponholtz, Todd
    Nguyen, Hiep T.
    Weissleder, Ralph
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04) : 1610 - 1614
  • [10] Golijanin DJ, 2007, CUAJ-CAN UROL ASSOC, V1, P305